Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Detecting a neoplastic clone associated with the common chromosome abnormalities seen in patients with various T-cell lymphomas
Tracking known chromosome abnormalities and response to therapy in patients with T-cell lymphomas
Providing potentially prognostic information in patients with documented systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma
Supporting the diagnosis of peripheral T-cell lymphoma when coordinated with consultation by anatomic pathology
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
_PRAH | Probe, Each Additional (TLYM) | No, (Bill Only) | No |
This test does not include a pathology consultation. If a pathology consultation is requested, PATHC / Pathology Consultation should be ordered and the appropriate FISH test will be ordered and performed at an additional charge. Mayo Hematopathology Consultants are involved in both the pre-analytic (tissue adequacy and probe selection, when applicable) and post-analytic (interpretation of FISH results in context of specific case, when applicable) phases.
A charge and CPT code is applied for each probe set hybridized, analyzed, and reported.
Depending on the lymphoma subtype suspected, the most appropriate probes to order are listed in the Clinical Information.
If the patient is being tracked for known abnormalities, indicate which probes should be used.
Panel includes testing for the following abnormalities using the probes listed:
14q32.1 rearrangement, TCL1A
14q11.2 rearrangement, TRAD
-7/7q-/i(7q), D7S486/D7Z1
+8, D8Z2/MYC
2p23.2 rearrangement, ALK
3q28 rearrangement, TP63 and TBL1XR1/TP63 (only performed when necessary to resolve or confirm TP63 rearrangement concerns)
6p25.3 rearrangement, IRF4 (DUSP22)
Fluorescence In Situ Hybridization (FISH)